Congenital dyserythropoietic anemia

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Congenital dyserythropoietic anemia | |
|---|---|
| Red blood cells | |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Anemia, jaundice, splenomegaly, gallstones |
| Complications | Iron overload, heart failure, liver disease |
| Onset | Congenital |
| Duration | Chronic |
| Types | Type I, Type II, Type III |
| Causes | Genetic mutation |
| Risks | Family history |
| Diagnosis | Blood test, bone marrow biopsy, genetic testing |
| Differential diagnosis | Hemolytic anemia, thalassemia, sideroblastic anemia |
| Prevention | N/A |
| Treatment | Blood transfusion, iron chelation therapy, splenectomy, bone marrow transplant |
| Medication | N/A |
| Prognosis | Variable, depending on type and treatment |
| Frequency | Rare |
| Deaths | N/A |
Congenital dyserythropoietic anemia (CDA) is a rare group of genetic disorders characterized by ineffective erythropoiesis, a process responsible for producing red blood cells. The term "congenital dyserythropoietic anemia" was first coined in 1968 to describe a group of conditions that are present from birth and involve the abnormal development of red blood cells.
Types[edit]
There are three main types of CDA: Type I, Type II, and Type III. Each type is distinguished by the genetic cause and the nature of the red blood cell abnormalities.
- CDA Type I is characterized by moderate to severe anemia, jaundice, and splenomegaly. It is caused by mutations in the CDAN1 gene.
- CDA Type II is the most common type of CDA. It is characterized by mild to severe anemia, jaundice, and splenomegaly. It is caused by mutations in the SEC23B gene.
- CDA Type III is the rarest type of CDA. It is characterized by mild anemia, and it is caused by mutations in the KIF23 gene.
Symptoms[edit]
The symptoms of CDA vary depending on the type, but they generally include fatigue, weakness, pale skin, and an enlarged liver and spleen. Some people with CDA may also have abnormal bone development, particularly in the fingers and toes.
Diagnosis[edit]
Diagnosis of CDA is based on a combination of clinical examination, blood tests, and genetic testing. The blood tests can reveal anemia and abnormal red blood cells, while genetic testing can identify the specific gene mutations causing the condition.
Treatment[edit]
Treatment for CDA is aimed at managing the symptoms and preventing complications. This may include blood transfusions, iron chelation therapy to remove excess iron from the body, and in severe cases, a bone marrow transplant.
See also[edit]